Implantable Drug Delivery Devices Market Analysis

  • Report ID: 3281
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Implantable Drug Delivery Devices Segmentation

The implantable drug delivery devices market is segmented on the basis of products into contraceptive implants, spinal implants, brachytherapy seeds, drug-eluting stents, bio-absorbable stents, intraocular implants, infusion pumps, and others, out of which, the drug-eluting stents segment is expected to dominate the global market during the forecast period, in terms of revenue, on account of increasing implementations of these implants in the medical industry for various indications such as cancer treatment, contraception, hormone regulation, and others.

Based on type, the biodegradable products segment is expected to witness significant growth over the forecast period in the market on the back of the its advantages over non-biodegradable products, which includes easy absorption, fabrication, and excretion of inter-polymers, greater acceptance rate, positive outcome, and others.  

Our in-depth analysis of the global market includes the following segments:

           Product

  • Contraceptive Implants
  • Spinal Implants
  • Brachytherapy Seeds
  • Drug-eluting Stents
  • Bio-absorbable Stents
  • Intraocular Implants
  • Infusion Pumps
  • Others

             Type

  • Biodegradable
  • Non-biodegradable

 

 

            Application

  • Contraception
  • Ophthalmology
  • Cardiovascular
  • Diabetes
  • Oncology
  • Auto-immune Diseases
  • Others

           End-User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of implantable drug delivery devices is assessed at USD 31.47 billion.

Implantable Drug Delivery Devices Market size was valued at USD 29.4 billion in 2024 and is expected to reach USD 82.89 billion by 2037, registering around 8.3% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is predicted to account for largest revenue share by 2037, on account of steadily increasing healthcare expenditure and rising concern & awareness for the development of advanced devices in the region.

The major players in the market include Boston Scientific Corporation, Merck & Co., Inc., Medtronic Plc, Allergan, Inc., Abbott Laboratories, DSM Biomedical, Varian Medical Systems, Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos